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Abstract
Introduction:  Mitral annulus calcification (MAC) is a common finding on echocardiographic
examination. The goal of this study was to evaluate associations between MAC and cardiac
abnormalities using a large echocardiographic database.
Methods: For this study we retrospectively reviewed 24,380 echocardiograms performed for
clinical reasons between the years 1984 and 1998.
Results:  MAC was reported in 1,494 (6.1%) subjects. Using multivariate analysis, age, left
ventricular hypertrophy (LVH), mitral regurgitation (MR), tricuspid regurgitation (TR), aortic
stenosis (AS), left atrial (LA) enlargement and reversed E/A ratio were independently associated
with MAC.)MAC was noted in 11.7 % of patients with MR vs. 4.3% without MR (OR: 2.0, CI 1.6–
2.6, p < 0.0001), in 13.9% of those with TR vs. 4.5% without TR (OR: 3.8, CI 2.9–4.8, p < 0.0001),
in 10.6% with LVH vs. 4.2% without LVH (OR: 1.9, CI 1.5–2.4, p < 0.0001), in 14.8% with AS vs.
5.5% without AS (OR: 1.4, CI 1.08–1.9, p = 0.01), in 9.4% with reversed E/A ratio vs. 3.8% without
reversed E/A ratio (OR: 1.7, CI 1.4–2.2, p < 0.0001) and in 8.2% with LA enlargement vs. 4.8%
without LA enlargement (OR: 1.3, CI 1.06–1.7, p = 0.02).
Conclusion:  In our study, MAC independently correlated with significant structural heart
abnormalities. This suggests that identification of MAC may serve as a marker for other cardiac
structural disorders.
Background
Idiopathic (degenerative) mitral annular calcification
(MAC) is one of the most common cardiac abnormalities
found upon autopsy. Four examples of normal, mild,
moderate and severe MAC can be seen in figure 1.
Although the development of degenerative calcification of
the mitral annulus is functionally of little consequence in
most hearts, it shares common risk factors with athero-
sclerosis; including systemic hypertension, hypercholeste-
rolemia, and diabetes [1]. Therefore it is important to risk-
stratify patients with MAC because of its association with
other important disorders such as coronary and carotid
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atherosclerosis and increased risk for cardiovascular mor-
bidity and mortality [1-3].
It has also been suggested that MAC might become an
important cause of mitral regurgitation (MR) when calci-
fication is severe [4,5]. Previous observational studies sug-
gest that MAC might be associated with several other
cardiovascular disorders such as atherosclerosis, MR,
stroke, atrioventricular conduction defects and hyper-
trophic cardiomyopathy [4-7]. In this study we analyzed a
large echocardiographic database of over 24,000 patients.
We performed comprehensive uni- and multivariate anal-
yses to evaluate associations between MAC and cardiac
abnormalities including valvular abnormalities, left ven-
tricular hypertrophy (LVH) and left atrial (LA) enlarge-
ment.
Methods
We retrospectively reviewed 24,380 echocardiograms per-
formed between the years 1984 and 1998, which were
ordered by clinicians for various indications. MAC and
other echocardiographic findings were diagnosed based
on the interpretation of echocardiograms by various car-
diologists using echocardiographic parameters on a com-
plete echocardiogram, including pulse and continuous
wave Doppler, Doppler color flow imaging and spectral
Doppler velocimetry studies. The documented final diag-
noses were available and used for our study. The reports
were generated by clinical cardiologists trained in the
interpretation of echocardiograms. The diagnosis of regur-
gitations included mild to severe, but trace regurgitations
that are commonly observed in healthy population were
not included in the diagnosis of regurgitations. Using uni-
and multivariate analysis, we evaluated the association
between age, gender, valvular abnormalities, pericardial
effusion, decreased fractional shortening (FS defined as FS
< 25%), left ventricular hypertrophy (LVH defined as left
ventricular wall thickness >11 mm measured in standard
parasternal long axis view involving at least one of the
ventricular walls), aortic thickening, aortic root enlarge-
ment (defined as aortic root over 35 mm measured in par-
asternal long axis), abnormal early over late mitral flow
reversal (reversed E/A ratio), body mass index (BMI>25)
and enlarged left atrial (LA defined as left atrial size > 40
mm measured in standard parasternal long axis view), tri-
cuspid regurgitation (TR), aortic regurgitation (AR) and
aortic stenosis (AS). The statistical analysis was performed
using SPSS software. A p-value of less than 0.05 was inter-
preted as statistically significant. Variables were analyzed
using  χ2  test. Quantitative variables were specified as
mean ± standard deviation. In the multivariate analysis, a
logistic regression model was utilized to calculate the
odds ratio and their 95% confidence interval to indicate
the strength of influence. We used SPSS statistical pro-
gram version 13 for the statistical analysis. Baseline clini-
cal characteristics of the patients were not available in the
database. The institutional review board approved this
study.
Results
MAC was diagnosed in 1,494 (6.1%) of the 24,380
echocardiograms. Using univariate analysis, MAC was sig-
nificantly associated with age, gender, MR, TR, AR AS,
thickened aortic valve; abnormal early over late mitral
flow reversal (reversed E/A ratio; dilated aortic root; LA
enlargement; BMI >25 and LVH. The association between
MAC and valvular regurgitations was independent of the
severity of regurgitation. Using multivariate analysis, age,
LVH, MR, TR, AS, LA enlargement and reversed E/A ratio
were independently associated with MAC. Mean age of
patients with MAC was 68 years vs. 50 years in those with-
out MAC (OR: 1.059, CI 1.054–1.062, p < 0.0001).)MAC
was noted in 11.7 % of patients with MR vs. 4.3% without
MR (OR: 2.0, CI 1.6–2.6, p < 0.0001), in 13.9% of those
with TR vs. 4.5% without TR (OR: 3.8, CI 2.9–4.8, p <
0.0001), in 10.6% with LVH vs. 4.2% without LVH (OR:
1.9, CI 1.5–2.4, p < 0.0001), in 14.8% with AS vs. 5.5%
without AS (OR: 1.4, CI 1.08–1.9, p = 0.01), in 9.4% with
reversed E/A ratio vs. 3.8% without reversed E/A ratio
(OR: 1.7, CI 1.4–2.2, p < 0.0001) and in 8.2% with LA
enlargement vs. 4.8% without LA enlargement (OR: 1.3,
CI 1.06–1.7, p = 0.02). There was no association between
MAC and mitral stenosis, decreased fractional shortening
or pericardial effusion (Table 1).
Discussion
Calcification within the mitral annulus results from a
degenerative process in the cardiovascular fibrous skele-
From left to right, examples of normal mitral annulus and cal- cified mitral annulus (mild = 1–2 mm, moderate = 2–5 mm  and severe >5 mm calcified annulus) Figure 1
From left to right, examples of normal mitral annulus and cal-
cified mitral annulus (mild = 1–2 mm, moderate = 2–5 mm 
and severe >5 mm calcified annulus).Cardiovascular Ultrasound 2007, 5:14 http://www.cardiovascularultrasound.com/content/5/1/14
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ton, which is reported to be accelerated by advanced age,
systemic hypertension, hypercholesterolemia, diabetes
mellitus, chronic renal failure with secondary hyperpar-
athyroidism and genetic abnormalities of the fibrous skel-
eton; such as, Marfan and Hurler syndromes [1,8,9]. The
initial pathologic event is considered to be fibrillar altera-
tion of the collagen ultrastructure [10]. This change trig-
gers lipid deposition and the subsequent development of
small foci of calcification deep within the annulus and at
points of interdigitation between the annulus and ven-
tricular muscle fibers.
Our study was conducted in order to evaluate association
between MAC and age, gender and other echocardio-
graphic cardiac abnormalities using a large number of
echocardiograms. We demonstrated that MAC was signif-
icantly associated with advanced age, valvular regurgita-
tions such as MR, TR and aortic stenosis, but not AR or
MS. It is suggested that when the mitral valve annulus
becomes thick, rigid and calcified, it may interfere with
valve closure, causing MR. In this setting, age is considered
to play a significant role in mitral valve degeneration, trig-
gering MAC. This association also explains the association
between advanced age and the occurrence of MAC. The
reason for MAC association with TR is not known. A sec-
ondary increase in the pulmonary arterial pressure due to
associated MR or AS may explain this association. Further-
more, patients with MAC are also at risk for calcification
in other vascular systems as a marker of atherosclerosis
and aging [3,6,8,11,12]. However, the independent asso-
ciation of MAC with AS in our study suggests that MAC
may play a direct role in the pathogenesis of AS or that
patients with MAC may represent a group of individuals
with increased susceptibility to generalized calcium depo-
sition in the cardiac and extra cardiac tissue. Fulkerson et
al., on the other hand, reported that conditions associated
with chronically increased left ventricular pressures, such
as aortic stenosis and systemic hypertension, enhance
stress on the mitral valve and apparatus or promote
abnormal valve motion. These effects are considered to
accelerate the degenerative process, leading to premature
calcium deposition as a possible explanation of our find-
ings [10]. Furthermore, our large population study con-
firms Fulkerson et al.'s observation that MAC was
significantly associated with LVH and AS. Coronary artery
disease and systemic calcified atherosclerosis have been
found to be strongly associated with MAC suggesting sim-
ilar pathogenesis in calcium deposition involving cardio-
vascular system [13,14]. Our study failed to show any
significant association between MAC and AR. It appears
that MAC does not decrease the integrity of aortic valve
that could lead to AR. We have a small number of patients
with mitral stenosis in our database limiting the assess-
ment of the association of MAC and mitral stenosis. Fin-
aly, MAC has been found to be associated with significant
cardiovascular morbidity and mortality [15] confirming
our finding that the presence of MAC could be marker for
underlying cardiovascular pathology.
Conclusion
This is the first large-scale study demonstrating that MAC
is independently associated with advanced age, MR, TR,
AS, diastolic mitral flow reversal, left atrial enlargement
and LVH. This suggests that identification of MAC may
serve as a marker for other cardiac structural disorders and
that patients with MAC may require further evaluation.
Limitations
This is a retrospective study that relied on previous
reports, resulting in non-uniform assessment of the
echocardiographic abnormalities. The diagnoses of car-
diac abnormalities were not standardized. Data regarding
criteria for diagnosis and grading of MAC was not availa-
ble. The sensitivity of the older equipments for detection
of MAC is probably less than the newer equipments. We
scored MAC in our study as absent or present. However, a
Table 1: Multivariate Odds ratios (OR) and confidential intervals (CI) for the association between MAC and various cardiac 
abnormalities:
OR 95% CI p
LVH 1. 9 1.5–2.4 < 0.0001
MR 2.0 1.6–2.6 < 0.0001
TR 3.8 2.9–4.8 < 0.0001
AR 0.9 0.7–1.2 0.52
AS 1.4 1.08–1.9 0.01
LAE 1.3 1.06–1.7 0.02
E/A reversal 1.7 1.4–2.2 < 0.0001
Age > 50 4.8 3.5–.6.4 < 0.0001
Male gender 0.8 0.65–1.02 0.08
BMI >25 1.1 0.9–1.4 0.4
DAR 1.2 0.9–1.6 0.2
LVH = Left Ventricular Hypertrophy, MR = Mitral Regurgitation, TR = Tricuspid Regurgitation, AR = Aortic Regurgitation, AS = Aortic Stenosis, 
Age in years, LAE = Left Atrial Enlargement, BMI = Body Mass Index, DAR = Dilated Aortic Root.Publish with BioMed Central    and   every 
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semiquantitative assessment of MAC severity could have
improved the study interpretation.
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